Related Experiment Videos

Global trends and advances in pediatric bronchiolitis treatment in the last two decades: a bibliometric analysis

Wei Li1, Jing Zhao2, Die Liu1

  • 1Department of Pediatrics, China-Japan Friendship Hospital, Beijing, China.

Journal of Thoracic Disease
|May 25, 2026
PubMed

Insights

This bibliometric analysis reveals global trends in pediatric bronchiolitis treatment research. Key areas include respiratory support, RSV therapy, and guidelines, with emerging focus on prevention and infection control.

Area of Science:

  • Pediatrics
  • Public Health
  • Bibliometrics

Background:

  • Bronchiolitis is a significant cause of infant morbidity globally.
  • This study addresses a gap by analyzing pediatric bronchiolitis treatment trends using bibliometrics.

Purpose of the Study:

  • To explore global trends and progress in pediatric bronchiolitis treatment.
  • To identify research hotspots and emerging topics in the field.

Main Methods:

  • Bibliometric analysis of 1,370 articles published between 2004-2024.
  • Literature search conducted in Web of Science Core Collection.
  • Data visualization and network analysis using VOSviewer, CiteSpace, and R 'bibliometrix'.

Main Results:

  • The United States led publications, followed by China and the UK.
  • Key institutions and journals were identified, with notable author contributions.
  • Thematic clusters included risk stratification, RSV therapy, respiratory support, guidelines, and clinical trials.
  • Emerging topics: epidemiology, prevention, infections, oxygen therapy, and guidelines.

Conclusions:

  • Past research focused on optimizing treatment: respiratory support, anti-RSV therapy, and guideline-based care.
  • Future research emphasizes prevention, infection control, and high-quality clinical trials for improved outcomes.
Abstract

Keywords:
Bronchiolitisbibliometricspediatric respiratory diseasetreatment trends

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...